These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset. Mullazehi M; Mathsson L; Lampa J; Rönnelid J Ann Rheum Dis; 2007 Apr; 66(4):537-41. PubMed ID: 17040962 [TBL] [Abstract][Full Text] [Related]
29. [The new serological markers of rheumatoid arthritis]. Tuchocka-Piotrowska A; Puszczewicz M Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699 [TBL] [Abstract][Full Text] [Related]
30. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N; Juillet F; Garnero P Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [TBL] [Abstract][Full Text] [Related]
31. [Immunologic tests: Anti-carbonic anhydrase II antibody]. Hosoda H; Okawa-Takatsuji M; Hasimoto N; Ikeda Y Nihon Rinsho; 2005 Jul; 63 Suppl 7():630-3. PubMed ID: 16111353 [No Abstract] [Full Text] [Related]
32. Inhibitory characteristics of citrullinated telopeptides of type I and II collagens for autoantibody binding in patients with rheumatoid arthritis. Koivula MK; Aman S; Alasaarela E; Karjalainen A; Hakala M; Risteli J Rheumatology (Oxford); 2006 Nov; 45(11):1364-9. PubMed ID: 16632481 [TBL] [Abstract][Full Text] [Related]